ENTITY

Biomarin Pharmaceutical (BMRN US)

57
Analysis
Health CareUnited States
BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin's subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology.
more
Company Event19 Feb 2026 05:30 • Upcoming
Add To Calendar
Company Event18 Nov 2025 18:30 • Latest
Company Event28 Oct 2025 04:30
Company Event05 Aug 2025 04:30
Company Event16 May 2025 20:45
x